The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 33,652 | 2,410,622 | SH | SOLE | 2,410,622 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 11,004 | 312,533 | SH | SOLE | 312,533 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,475 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 41,393 | 4,479,784 | SH | SOLE | 4,479,784 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 8,376 | 920,464 | SH | SOLE | 920,464 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 14,526 | 538,812 | SH | SOLE | 538,812 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 44,601 | 4,944,708 | SH | SOLE | 4,944,708 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 16,929 | 5,738,500 | SH | SOLE | 5,738,500 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 35,111 | 893,646 | SH | SOLE | 893,646 | 0 | 0 | ||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 13,240 | 739,661 | SH | SOLE | 739,661 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 3,099 | 893,013 | SH | SOLE | 893,013 | 0 | 0 | ||
| INVENTIVA SA | ADS | 46124U107 | 995 | 175,500 | SH | SOLE | 175,500 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 23,184 | 2,409,961 | SH | SOLE | 2,409,961 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,076 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 8,730 | 1,935,609 | SH | SOLE | 1,935,609 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 33,480 | 1,826,491 | SH | SOLE | 1,826,491 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 59,221 | 2,615,762 | SH | SOLE | 2,615,762 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 3,908 | 1,210,000 | SH | SOLE | 1,210,000 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 15,365 | 3,711,286 | SH | SOLE | 3,711,286 | 0 | 0 | ||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 2,014 | 357,699 | SH | SOLE | 357,699 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 19,635 | 2,028,453 | SH | SOLE | 2,028,453 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 18,959 | 1,638,609 | SH | SOLE | 1,638,609 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 11,483 | 13,049,079 | SH | SOLE | 13,049,079 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 48,518 | 1,594,932 | SH | SOLE | 1,594,932 | 0 | 0 | ||